ArticleNPJ vaccines2022

Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial.

Luke Tzu-Chi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.